Michael A Metzger Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael A Metzger.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael A Metzger. Michael A Metzger is Director in CTI BIOPHARMA CORP ($CTIC) and Director in RESPONSE GENETICS INC ($RGDX) and President and COO in Syndax Pharmaceuticals Inc ($SNDX).
Latest Insider Trading Transactions of Michael A Metzger
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CTIC, RGDX, SNDX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 12 2021 | CTIC | CTI BIOPHARMA CORP | Metzger Michael A | Director | Option Exercise | A | 3.30 | 80,000 | 264,000 | 80,000 | |
Feb 05 2021 | SNDX | Syndax Pharmaceuti ... | Metzger Michael A | President and COO | Option Exercise | A | 21.36 | 160,000 | 3,417,600 | 160,000 | |
Feb 03 2021 | SNDX | Syndax Pharmaceuti ... | Metzger Michael A | President and COO | Option Exercise | M | 7.20 | 15,000 | 108,000 | 0 | |
Feb 03 2021 | SNDX | Syndax Pharmaceuti ... | Metzger Michael A | President and COO | Sell | S | 20.19 | 15,000 | 302,799 | 17,659 | 32.7 K to 17.7 K (-45.93 %) |
Feb 03 2021 | SNDX | Syndax Pharmaceuti ... | Metzger Michael A | President and COO | Buy | M | 7.20 | 15,000 | 108,000 | 32,659 | 17.7 K to 32.7 K (+84.94 %) |
Nov 06 2020 | SNDX | Syndax Pharmaceuti ... | Metzger Michael A | President and COO | Option Exercise | M | 7.20 | 100,000 | 720,000 | 0 | |
Nov 06 2020 | SNDX | Syndax Pharmaceuti ... | Metzger Michael A | President and COO | Sell | S | 20.31 | 100,000 | 2,031,410 | 17,659 | 117.7 K to 17.7 K (-84.99 %) |
Nov 06 2020 | SNDX | Syndax Pharmaceuti ... | Metzger Michael A | President and COO | Buy | M | 7.20 | 100,000 | 720,000 | 117,659 | 17.7 K to 117.7 K (+566.28 %) |
Mar 13 2020 | CTIC | CTI BIOPHARMA CORP | Metzger Michael A | Director | Option Exercise | A | 1.00 | 126,000 | 126,000 | 126,000 | |
Feb 14 2020 | SNDX | Syndax Pharmaceuti ... | Metzger Michael A | President and COO | Option Exercise | A | 9.47 | 140,000 | 1,325,800 | 140,000 | |
Feb 14 2020 | SNDX | Syndax Pharmaceuti ... | Metzger Michael A | President and COO | Grant | A | 0.00 | 15,000 | 0 | 17,659 | 2.7 K to 17.7 K (+564.12 %) |
Jul 08 2019 | SNDX | Syndax Pharmaceuti ... | Metzger Michael A | President and COO | Option Exercise | A | 9.15 | 200,000 | 1,830,000 | 200,000 | |
May 20 2019 | CTIC | CTI BIOPHARMA CORP | Metzger Michael A | Director | Option Exercise | A | 0.84 | 120,000 | 100,932 | 120,000 | |
Feb 08 2019 | SNDX | Syndax Pharmaceuti ... | Metzger Michael A | President and COO | Option Exercise | A | 6.38 | 240,000 | 1,531,200 | 240,000 | |
Feb 08 2019 | SNDX | Syndax Pharmaceuti ... | Metzger Michael A | President and COO | Buy | J | 4.76 | 2,659 | 12,657 | 2,659 | 0 to 2.7 K |
May 17 2018 | CTIC | CTI BIOPHARMA CORP | Metzger Michael A | Director | Option Exercise | A | 4.61 | 60,000 | 276,600 | 60,000 | |
Mar 05 2018 | SNDX | Syndax Pharmaceuti ... | Metzger Michael A | President and COO | Option Exercise | A | 9.40 | 125,000 | 1,175,000 | 125,000 | |
Jan 22 2018 | CTIC | CTI BIOPHARMA CORP | Metzger Michael A | Director | Option Exercise | M | 0.00 | 20,121 | 0 | 0 | |
Jan 22 2018 | CTIC | CTI BIOPHARMA CORP | Metzger Michael A | Director | Buy | M | 0.00 | 20,121 | 0 | 20,121 | 0 to 20.1 K |
Feb 27 2017 | CTIC | CTI BIOPHARMA CORP | Metzger Michael A | Director | Option Exercise | A | 4.25 | 50,000 | 212,500 | 50,000 | |
Feb 08 2017 | SNDX | Syndax Pharmaceuti ... | Metzger Michael A | President and COO | Option Exercise | A | 8.77 | 95,000 | 833,150 | 95,000 | |
Jan 24 2017 | CTIC | CTI BIOPHARMA CORP | Metzger Michael A | Director | Option Exercise | A | 0.00 | 20,121 | 0 | 20,121 | |
Aug 01 2012 | RGDX | RESPONSE GENETICS ... | Metzger Michael A | Director | Option Exercise | A | 1.16 | 20,000 | 23,200 | 20,000 | |
Feb 06 2012 | RGDX | RESPONSE GENETICS ... | Metzger Michael A | Director | Buy | P | 1.50 | 1,000 | 1,500 | 1,000 | 0 to 1,000 |
Oct 17 2011 | RGDX | RESPONSE GENETICS ... | Metzger Michael A | Director | Option Exercise | A | 1.66 | 11,500 | 19,090 | 11,500 | |
Apr 14 2011 | RGDX | RESPONSE GENETICS ... | Metzger Michael A | Director | Option Exercise | A | 2.25 | 11,500 | 25,875 | 11,500 | |
Dec 07 2010 | RGDX | RESPONSE GENETICS ... | Metzger Michael A | Director | Option Exercise | A | 2.35 | 11,500 | 27,025 | 11,500 |
Page: 1